MDGL
Madrigal Pharmaceuticals Inc
Price:  
346.40 
USD
Volume:  
192,586.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDGL WACC - Weighted Average Cost of Capital

The WACC of Madrigal Pharmaceuticals Inc (MDGL) is 7.9%.

The Cost of Equity of Madrigal Pharmaceuticals Inc (MDGL) is 7.95%.
The Cost of Debt of Madrigal Pharmaceuticals Inc (MDGL) is 5.00%.

Range Selected
Cost of equity 6.60% - 9.30% 7.95%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 9.2% 7.9%
WACC

MDGL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.6 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 9.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.02 0.02
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 9.2%
Selected WACC 7.9%